Age-related Vision Dysfunction Market Trends Analysis By DelveInsight
DelveInsight's "Age-related Vision Dysfunction Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Age-related Vision Dysfunction market size and shares analysis in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Age-related macular degeneration primarily affects the macula — a tiny portion found at the center of the retina and responsible for sharp central vision. AMD comes in two types — dry and wet. Each type requires different treatment approaches. According to WHO, AMD is damage to the central part of the retina responsible for detailed vision that leads to dark patches, shadows, or distortion of the central vision. The risk of developing macular degeneration increases with age.
Risk factors for, and causes of, eye conditions include aging, genetics, lifestyle exposure and behaviors, infections, and various health conditions. Many eye conditions are multifactorial in origin. Many risk factors increase the likelihood of developing or contributing to the progression of, an eye condition. These include aging, lifestyle exposure and behaviors, infections, and a range of health conditions.
Age-related Vision Dysfunction Market Key Facts
- According to the U.S. Census population (2010), approximately 63% of the adults over the age of 40 in the United States experienced vision problems attributable to vision impairment, blindness, refractive error (i.e., myopia and hyperopia), age-related macular degeneration (AMD), cataracts, diabetic retinopathy, and glaucoma.
- As per the study conducted by Varma et al. (2016), in 2015 for persons 40 years and older in the United States, the overall estimated prevalence of vision impairment was 2.14%, and the overall estimated prevalence of blindness was 0.68%
- As per the study conducted by Durieux et al. (2014), titled “Prevalence of Age-Related Macular Degeneration in the north of France,” prevalence of AMD is 8% after the age of 50 years, more than 30% after 75 years old with more cases in women (65%) than in men (35%).
Age-related Vision Dysfunction Market Analysis
The Age-related Vision Dysfunction market analysis section of the report helps to understand the current and forecasted Age-related Vision Dysfunction market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Age-related Vision Dysfunction market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Age-related Vision Dysfunction Treatment market
The Age-Related Vision Dysfunction treatment depends on the cause or the disease type. Both pharmacological and non-pharmacological treatment options are available. There's no cure, but treatment for age-related macular degeneration (AMD) may slow the disease and keep the patient away from having a severe loss of vision. Treatment options include anti-angiogenic drugs, laser therapy, and photodynamic laser therapy.
The rise in the geriatric population among 7MM countries is one of the major reasons for the increase in the prevalence of Age-related vision dysfunction. These factors along with the expected launch of emerging therapies will boost the Age-related Vision Dysfunction Market Size in the coming years.
Age-related Vision Dysfunction Companies:
- AceVision Group
- Kodiak Sciences
- Pixium Vision
- Outlook Therapeutics’s
- Bausch & Lomb Incorporated
And others.
Age-related Vision Dysfunction Therapies covered in the report include:
- Vyzulta
- PRIMA
- KSI-301
- LaserACE
- ONS-5010 /LYTENAVA
And many more.
Age-related Vision Dysfunction Epidemiology Forecast
The Age-related Vision Dysfunction epidemiology section covers insights about historical and current Age-related Vision Dysfunction patient pool and forecasted trends for every seven major countries (i.e., the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
It helps to recognize the causes of current and forecasted Age-related Vision Dysfunction Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Age-related Vision Dysfunction Epidemiology Segmentation
- Total Prevalent Cases of Age-Related Vision Dysfunction
- Age-specific Prevalent Cases of Age-Related Vision Dysfunction
- Gender-specific Prevalent Cases of Age-Related Vision Dysfunction
- Type-specific Prevalent Cases of Age-Related Vision Dysfunction
- Diagnosed and Treatable Cases of Age-Related Vision Dysfunction
For more details, visit: Age-related Vision Dysfunction Market Trends